El-Dorado Biotech Private Limited

El-Dorado Biotech Private Limited - pharma in Aurangabad, Maharashtra, India. FY 2026 financials & compliance.
CIN U24230MH2002PTC138220 Incorporated 11 December 2002 ROC Mumbai HQ Aurangabad, Maharashtra, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2025
₹25.63 Cr
▲ 64% YoY
Net profit · FY 2025
₹1.22 Cr
Net margin 4.8%
EBITDA · FY 2025
₹1.98 Cr
EBITDA margin 7.7%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹9.57 Lakh
Issued & subscribed
Open charges
₹48.4 Lakh
Secured borrowings
Company age
24 yrs
Est. 2002
Directors on board
2
As per MCA filings

About El-Dorado Biotech Private Limited

Data last updated:

El-Dorado Biotech Private Limited is a private limited company based in Aurangabad, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 11 December 2002 and has been in existence for over 24 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH2002PTC138220. Its GSTIN is 27AABCE1817D1Z4 (Maharashtra).

The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹9.57 Lakh. It is led by directors Vinay Vasant Joshi and Vandana Vinay Joshi.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Block A Plot No. 22 Gut No. 53 Sajapur, Aurangabad, Maharashtra, India – 431136.

As per the financials filed for FY 2025, the company reported a revenue of ₹25.63 Cr, a growth of 64% compared to the previous year. For the same year it recorded a net profit of ₹1.22 Cr (net margin 4.8%) and EBITDA of ₹1.98 Cr (EBITDA margin 7.7%). Revenue has grown at a compounded annual rate (CAGR) of 55% over three years and 36% over five years.

The company is associated with 1 brand: El-Dorado Biotech. As per MCA filings, the company has open charges of ₹48.4 Lakh on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website eldoradobiotech.com.

Company Details of El-Dorado Biotech Private Limited
CIN U24230MH2002PTC138220
Registration Number 138220
Incorporation Date 11 December 2002
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Social Media
  • Registered Address
    Block A Plot No. 22 Gut No. 53 Sajapur, Aurangabad, Maharashtra, India – 431136
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors
Comprehensive company report
El-Dorado Biotech Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full El-Dorado Biotech Private Limited report

Financials, compliance, directors, charges, ownership and filings for El-Dorado Biotech Private Limited in one report.

Financials from 2015 Directors & ownership Charges & compliance

Business Activity of El-Dorado Biotech Private Limited

The main business activity of El-Dorado Biotech is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main Activity Group CodeDescription of Main ActivityBusiness Activity CodeDescription of Business ActivityTurnover Percentage
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical productsLocked
Premium access

Business activity turnover details

Turnover share and past changes in activity are in the company report.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Financials of El-Dorado Biotech Private Limited FY 2025 filings available

El-Dorado Biotech Private Limited reported revenue of ₹25.63 Cr (up 64% YoY) for FY 2025.

Revenue · FY 2025
₹25.63 Cr ▲ 64%
Net profit · FY 2025
₹1.22 Cr margin 4.8%
EBITDA · FY 2025
₹1.98 Cr margin 7.7%

Compounded Annual Growth Rate (CAGR) of El-Dorado Biotech Private Limited

Revenue CAGR growth
1 year
▲ 64%
3 years · compounded
▲ 55%
5 years · compounded
▲ 36%
EBITDA CAGR growth
1 year
▲ 95%
3 years · compounded
▲ 39%
5 years · compounded
▲ 19%

Revenue has grown at a compounded annual rate (CAGR) of 36% over five years, including 64% growth in the latest year. EBITDA rose 95% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary of El-Dorado Biotech Private Limited

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations••••••••••••••••••••
Other Income••••••••••••••••••••
Total Revenue••••••••••••••••••••
Cost of Materials Consumed••••••••••••••••••••
Employee Benefit Expense••••••••••••••••••••
Finance Costs••••••••••••••••••••
Depreciation and Amortisation••••••••••••••••••••
Other Expenses••••••••••••••••••••
Total Expenses••••••••••••••••••••
EBITDA₹1.98 Cr••••••••••••••••
Profit Before Tax••••••••••••••••••••
Tax Expense••••••••••••••••••••
Net Profit (PAT)₹1.22 Cr••••••••••••••••
Balance Sheet
Share Capital••••••••••••••••••••
Reserves and Surplus••••••••••••••••••••
Net Worth (Total Equity)••••••••••••••••••••
Long-term Borrowings••••••••••••••••••••
Short-term Borrowings••••••••••••••••••••
Trade Payables••••••••••••••••••••
Total Liabilities••••••••••••••••••••
Fixed Assets••••••••••••••••••••
Investments••••••••••••••••••••
Inventories••••••••••••••••••••
Trade Receivables••••••••••••••••••••
Cash and Bank Balance••••••••••••••••••••
Total Assets••••••••••••••••••••

Financial Ratios of El-Dorado Biotech Private Limited

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin7.7%••••••••••••••••
Net Profit Margin4.8%••••••••••••••••
Return on Equity (ROE)••••••••••••••••••••
Return on Capital Employed (ROCE)••••••••••••••••••••
Return on Assets (ROA)••••••••••••••••••••
Liquidity and Debt
Current Ratio••••••••••••••••••••
Quick Ratio••••••••••••••••••••
Debt-to-Equity Ratio••••••••••••••••••••
Interest Coverage Ratio••••••••••••••••••••
Efficiency and Growth
Asset Turnover••••••••••••••••••••
Receivable Days••••••••••••••••••••
Payable Days••••••••••••••••••••
Inventory Days••••••••••••••••••••
Revenue Growth••••••••••••••••••••
Net Profit Growth••••••••••••••••••••

Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of El-Dorado Biotech are in the company report.

Premium access

Financial statements from 2015

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Peer Comparison of El-Dorado Biotech Private Limited

El-Dorado Biotech Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution). Net profit, margin and employee counts of each company are in the company report.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Darwin Platform Pharmaceuticals Limited₹25.84 Cr (FY 2024)••••••••0.0%••••Mumbai, Maharashtra, India
Ether Pharmaceuticals Private Limited₹25.81 Cr (FY 2025)••••••••24.0%••••Delhi, India
Ravenbhel Pharmaceuticals Private Limited₹25.73 Cr (FY 2024)••••••••7.0%••••Amritsar, Punjab, India
Traxo Medserve Private Limited₹25.73 Cr (FY 2024)••••••••0.0%••••Ahmedabad, Gujarat, India
Krishaa Biotech Private Limited₹25.7 Cr (FY 2018)••••••••24.0%••••Kolkata, West Bengal, India
El-Dorado Biotech Private Limited this company₹25.63 Cr (FY 2025)••••••••64.0%••••Aurangabad, Maharashtra, India
Asston Pharmaceuticals Limited₹25.61 Cr (FY 2025)••••••••57.0%••••Thane, Maharashtra, India
Kalpana Nursing Home Private Limited₹25.52 Cr (FY 2024)••••••••11.0%••••Udaipur, Rajasthan, India
Medrev Healthcare Private Limited₹25.47 Cr (FY 2024)••••••••39.0%••••Delhi, India
Midland Super Speciality Hospital Private Limited₹25.24 Cr (FY 2025)••••••••15.0%••••Lucknow, Uttar Pradesh, India
Rainbow Life Sciences Private Limited₹25.18 Cr (FY 2025)••••••••-12.0%••••Navi Mumbai, Maharashtra, India

Peers are the five companies nearest above and the five nearest below El-Dorado Biotech by revenue in the Pharma industry (Pharma Retail and Distribution), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.

Auditor Details of El-Dorado Biotech Private Limited

El-Dorado Biotech Private Limited is audited by R B SHARMA & CO for the financial year 2021.

NameStatusAppointment DateCessation Date
R B SHARMA & COLockedLockedLocked
Premium access

Complete auditor history

Appointment and cessation dates and past auditor changes are in the company report.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of El-Dorado Biotech Private Limited

El-Dorado Biotech has 2 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Vinay Vasant JoshiDirector11 Dec 200223 Years 9 MonthsCurrent
Vandana Vinay JoshiDirector15 Dec 200520 Years 9 MonthsCurrent

Ownership and Shareholding of El-Dorado Biotech Private Limited

Premium access

Shareholding and ownership data

Promoter, institutional, public and beneficial ownership figures are in the company report.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of El-Dorado Biotech Private Limited

Open charges
₹48.4 Lakh
Satisfied charges
None
Breakdown by lending institutions
Others₹0.48 Cr
Latest charge details
DateLenderAmountStatus
30 Apr 2024Others₹48.4 LakhOpen

Total charge records: 1 View all charges

Associated Brands with El-Dorado Biotech Private Limited

El-Dorado Biotech operates one associated brand: El-Dorado Biotech. Each brand links to its own profile.

BrandDescriptionWebsite
Conducts R&D and manufactures drugs for various therapeutic areas.eldoradobiotech.com

Employees and EPFO Compliance at El-Dorado Biotech Private Limited

Employment history and EPFO contributions of people linked to El-Dorado Biotech.

Premium access

Employee and EPFO history

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

Recent Activity on El-Dorado Biotech Private Limited

El-Dorado Biotech Private Limited has 2 board changes on record since 2002: 2 appointments. The latest: Vandana Vinay Joshi was appointed as Director on 15 Dec 2005.

AGM
El-Dorado Biotech Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
El-Dorado Biotech Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai Ii.
Charges
A charge with Others amounted to Rs. 48.40 Lakh with Charge ID 100933012 was registered on 30 Apr 2024.
Appointed
Vandana Vinay Joshi was appointed as Director.
Appointed
Vinay Vasant Joshi was appointed as Director.
Incorporation
11 Dec 2002
El-Dorado Biotech Private Limited was registered on 11 Dec 2002 with Roc Mumbai Ii & aged 23 years 9 months as per MCA records.

Credit Ratings, Litigation & Regulatory Alerts for El-Dorado Biotech Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by El-Dorado Biotech Private Limited

Premium access

MSME payment history

Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of El-Dorado Biotech Private Limited

Premium access

Corporate group structure

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

GST Compliance of El-Dorado Biotech Private Limited

El-Dorado Biotech has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
27AABCE1817D1Z4MaharashtraActive01 Jul 2017
Premium access

GST registrations and filing compliance

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

MCA Filings & Documents of El-Dorado Biotech Private Limited

Premium access

MCA filings and documents

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Frequently Asked Questions about El-Dorado Biotech Private Limited

El-Dorado Biotech is an active private limited company based in Aurangabad, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 11 December 2002 (24+ years old) and is registered under CIN U24230MH2002PTC138220.

El-Dorado Biotech reported revenue of ₹25.63 Cr for FY 2025 (up 64% YoY).

El-Dorado Biotech has 2 current directors:

El-Dorado Biotech reported a net profit of ₹1.22 Cr (net margin 4.8%) and EBITDA of ₹1.98 Cr (EBITDA margin 7.7%) for FY 2025, as per its filed financial statements.

The compounded annual growth rate (CAGR) of the revenue of El-Dorado Biotech is 55% over three years and 36% over five years. In the latest year (FY 2025) revenue rose 64%. CAGR is the steady yearly rate that links the first and the last year.

The GSTIN of El-Dorado Biotech is 27AABCE1817D1Z4, registered in Maharashtra.

The CIN (Corporate Identification Number) of El-Dorado Biotech is U24230MH2002PTC138220. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

El-Dorado Biotech was incorporated on 11 December 2002, making it 24+ years old. It is registered with the Registrar of Companies, Mumbai.

The peers of El-Dorado Biotech by revenue are Darwin Platform Pharmaceuticals Limited, Ether Pharmaceuticals Private Limited, Ravenbhel Pharmaceuticals Private Limited, Traxo Medserve Private Limited, Krishaa Biotech Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution).

Vandana Vinay Joshi was appointed as Director on 15 Dec 2005. Vinay Vasant Joshi was appointed as Director on 11 Dec 2002.

El-Dorado Biotech can be reached through the website eldoradobiotech.com. Its registered office is in Aurangabad, Maharashtra, India.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available